Vera Therapeutics (VERA) Stock: Buy, Sell, or Hold?
VERA - Vera Therapeutics, Inc. Class A Common Stock
$29.42
-1.00 (-3.29%)
▼
5d:
-9.48%
30d:
-15.92%
90d:
-31.52%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
29d
Get Alerted When VERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: VERA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: VERA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: VERA is currently trading at $29.42, which is considered oversold relative to its 30-day fair value range of $32.41 to $35.37.
Technical Outlook: Technically, VERA is in a downtrend. The price is currently testing key support at $29.80. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $77.50 (+154.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VERA is in a downtrend. The price is currently testing key support at $29.80. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $77.50 (+154.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$32.41 -
$35.37
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 154.8% below Wall St target ($77.50)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$32.41 -
$35.37
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$29.80
Resistance Level
$36.50
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.14
Wall Street Target
$77.50
(+154.8%)
Share & Embed Analysis
Last updated: October 05, 2026 11:32 AM ET
Data refreshes hourly during market hours. Next update: 12:32 PM
Data refreshes hourly during market hours. Next update: 12:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VERA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Marshall Fordyce
SELL
22951 shares
2026-04-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
23 analysts |
$257 | 53 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 73 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$74 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
20 analysts |
$95 | 57 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$38 | 70 BUY |
